Prosight Management, LP Magenta Therapeutics, Inc. Transaction History

Prosight Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$7.66 - $13.38 $962,509 - $1.68 Million	-125,654 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$6.1 - $7.94 $723,447 - $941,668	-118,598 Reduced 48.56%	125,654 $985,000
Q3 2020 Nov 13, 2020	BUY	$6.52 - $8.94 $493,394 - $676,525	75,674 Added 44.89%	244,252 $1.66 Million
Q2 2020 Aug 14, 2020	BUY	$6.18 - $10.76 $1.04 Million - $1.81 Million	168,578 New	168,578 $1.27 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

Stay updated on Prosight Management, LP with notifications on news.